期刊名：Current Oncology

期刊主页：https://www.mdpi.com/journal/curroncol

在肿瘤学研究不断发展的背景下，神经系统肿瘤因其高度复杂性和治疗挑战性，始终是研究的重点与难点。本期汇总了Current Oncology期刊的编辑精选文章，特别关注胶质瘤、脑转移瘤及其他中枢神经系统肿瘤的前沿进展。通过系统探讨肿瘤生物学机制、影像学诊断、手术及综合治疗策略，我们期待激发更多跨学科的研究思路与临床合作，以改善神经肿瘤患者的预后与生活质量。

1. Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes

替莫唑胺（TMZ）在多形性胶质母细胞瘤治疗中的应用——文献综述与临床结局分析

https://www.mdpi.com/1718-7729/31/7/296

Jezierzański, M.; Nafalska, N.; Stopyra, M.; Furgol, T.; Miciak, M.; Kabut, J.; Gisterek-Grocholska, I. Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes. Curr. Oncol. 2024, 31, 3994-4002.

2. Survival after Stereotactic Radiosurgery in the Era of Targeted Therapy: Number of Metastases No Longer Matters

靶向治疗时代立体定向放射外科后的生存：转移灶数量已不再是决定因素

https://www.mdpi.com/1718-7729/31/6/228

de Boisanger, J.; Brewer, M.; Fittall, M.W.; Tran, A.; Thomas, K.; Dreibe, S.; Creak, A.; Solda, F.; Konadu, J.; Taylor, H.; et al. Survival after Stereotactic Radiosurgery in the Era of Targeted Therapy: Number of Metastases No Longer Matters. Curr. Oncol. 2024, 31, 2994-3005.

3. Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics

胶质母细胞瘤生存结局预测：来自MRI影像组学的见解

https://www.mdpi.com/1718-7729/31/4/165

Styliara, E.I.; Astrakas, L.G.; Alexiou, G.; Xydis, V.G.; Zikou, A.; Kafritsas, G.; Voulgaris, S.; Argyropoulou, M.I. Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics. Curr. Oncol. 2024, 31, 2233-2243.

4. An Overview of CD133 as a Functional Unit of Prognosis and Treatment Resistance in Glioblastoma

CD133作为胶质母细胞瘤预后及治疗耐药功能单元的研究综述

https://www.mdpi.com/1718-7729/30/9/601

Joyce, T.; Jagasia, S.; Tasci, E.; Camphausen, K.; Krauze, A.V. An Overview of CD133 as a Functional Unit of Prognosis and Treatment Resistance in Glioblastoma. Curr. Oncol. 2023, 30, 8278-8293.

5. Neurologic Complications of Cancer Immunotherapy

中文标题: 癌症免疫治疗的神经系统并发症

https://www.mdpi.com/1718-7729/30/6/440

Alsalem, A.N.; Scarffe, L.A.; Briemberg, H.R.; Aaroe, A.E.; Harrison, R.A. Neurologic Complications of Cancer Immunotherapy. Curr. Oncol. 2023, 30, 5876-5897.

6. The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors

免疫治疗在罕见中枢神经系统肿瘤治疗中的作用

https://www.mdpi.com/1718-7729/30/6/401

Rodriguez, A.; Kamiya-Matsuoka, C.; Majd, N.K. The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors. Curr. Oncol. 2023, 30, 5279-5298.

7. Pediatric Brain Tumours: Lessons from the Immune Microenvironment

儿童脑肿瘤：来自免疫微环境的启示

https://www.mdpi.com/1718-7729/30/5/379

Yao, B.; Delaidelli, A.; Vogel, H.; Sorensen, P.H. Pediatric Brain Tumours: Lessons from the Immune Microenvironment. Curr. Oncol. 2023, 30, 5024-5046.

8. Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine

脑肿瘤影像中的人工智能：迈向个体化医疗的一步

https://www.mdpi.com/1718-7729/30/3/203

Cè, M.; Irmici, G.; Foschini, C.; Danesini, G.M.; Falsitta, L.V.; Serio, M.L.; Fontana, A.; Martinenghi, C.; Oliva, G.; Cellina, M. Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine. Curr. Oncol. 2023, 30, 2673-2701.

9. Temozolomide Chronotherapy in Glioma: A Systematic Review

胶质瘤中替莫唑胺时间治疗策略：系统综述

https://www.mdpi.com/1718-7729/30/2/147

Jia, J.L.; Alshamsan, B.; Ng, T.L. Temozolomide Chronotherapy in Glioma: A Systematic Review. Curr. Oncol. 2023, 30, 1893-1902.

10. A 3-miRNA Signature Enables Risk Stratification in Glioblastoma Multiforme Patients with Different Clinical Outcomes

3-miRNA特征模型实现多形性胶质母细胞瘤患者的风险分层及不同临床结局预测

https://www.mdpi.com/1718-7729/29/6/345

Bafiti, V.; Ouzounis, S.; Chalikiopoulou, C.; Grigorakou, E.; Grypari, I.M.; Gregoriou, G.; Theofanopoulos, A.; Panagiotopoulos, V.; Prodromidi, E.; Cavouras, D.; et al. A 3-miRNA Signature Enables Risk Stratification in Glioblastoma Multiforme Patients with Different Clinical Outcomes. Curr. Oncol. 2022, 29, 4315-4331.

期刊介绍

主编：Prof. Dr. Shahid Ahmed, University of Saskatchewan; Saskatoon Cancer Center, Canada

Current Oncology （ISSN 1718-7729）自1994年创刊以来，致力于通过发表临床相关研究并直接应用于肿瘤学实践，推动癌症护理和治疗的发展。该期刊发表的文章通常包含与临床肿瘤学实践直接相关的信息，并具有应用于当前或未来癌症医学实践的明确潜力。Current Oncology 与多个重要的癌症协会合作，提供了一个分享肿瘤学科学进展的全球平台。